- Blood Glucose Meter
- Blood Glucose Testing Strips
- Lancets
- Others
Self-Monitoring Blood Glucose Devices Market size was valued at USD 12.82 billion in 2022. It is expected to reach a value of USD 22.84 billion by 2028, at a significant CAGR of 8.6% from 2023-2029. Self-monitoring blood glucose technology methods are small, portable devices that can detect disease risk. These instruments often take a tiny blood sample from patients by pricking their fingertips in order to measure their blood sugar levels. This approach is advised by international recommendations for effectively managing diabetes in patients. The blood glucose concentration is measured using a self-monitoring blood glucose monitor. The COVID-19 pandemic had a favourable effect on the expansion of the self-monitoring blood glucose market. Diabetes problems, aberrant glucose variability, and increased blood glucose levels may be experienced by COVID-19-infected patients who have diabetes.
The COVID-19 emergency has highlighted the significance of self-monitoring blood glucose devices, therefore it is important to keep an eye on a patient's blood glucose monitoring to prevent aggravation. Going forward, it is anticipated that the market for self-monitoring blood glucose devices would expand due to the increased prevalence of diabetes. Self-monitoring of blood glucose is a technique whereby a person with diabetes uses a glycemic reading device to measure their blood sugar (glucose metre) so that they can adjust or monitor the effectiveness of their treatment (diet, exercise, insulin, antidiabetics), or see their doctor, based on the test results.
Self-Monitoring Blood Glucose Devices Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
8.6%
Largest Market
North-America
Fastest Growing Market
Europe
Self-Monitoring Blood Glucose Devices Market Dynamics
A substantial proportion of persons in the United States carry genes for bleeding and clotting diseases, as well as hemoglobinopathies, according to the Office of Disease Prevention and Health Promotion. Blood clots in leg veins affect over 1.2 million people in the United States. Deep venous thrombosis is the medical term for this illness (DVT). Hemoglobin disorders were once endemic in 60 percent of 229 countries, potentially affecting 75 percent of births; however, they are now common in 71 percent of countries, affecting 89 percent of births (either in the entire population or among minorities), prompting policymakers to consider the most appropriate treatment and prevention strategy. A major variation affects at least 5.2 percent of the world's population (and over 7% of pregnant women). Due to a localised very high carrier prevalence, haemoglobin S accounts for 40% of carriers but causes over 80% of problems: over 85% of sickle-cell disorders and over 70% of all affected infants occur in Africa. As a result, the market is likely to be driven by increased blood diseases.
North-America got significant share
Self-Monitoring Blood Glucose Devices Market Regional Analysis
Because of the high prevalence of diabetes in the region, North America dominated the market for self-monitoring blood glucose monitors. Furthermore, the presence of major competitors in the region aids the market's expansion. However, due to an increase in diabetes prevalence in the area, Asia-Pacific is predicted to grow at the quickest rate throughout the projection period. Furthermore, nations in the region, such as India and China, have the largest populations of undiagnosed diabetics. Furthermore, the ever-changing healthcare business propels market expansion in developing countries.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- Global Self-Monitoring Blood Glucose Devices Market expanding at significant CAGR over 2023-2029 owing to growing demand for detergents globally
- Based on form, Product segment accounted for larger market revenue share in 2021 and projected gain market revenue share over the forecast period
- Players focusing on innovation of newer products and collaboration strategies to retain market position in global sodium silicate market
Self-Monitoring Blood Glucose Devices Market Segmentation
By Product
By End User
- Hospitals
- Clinics
- Diagnostic Centers
- Homecare
By Geography
North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America
Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA
Frequently Asked Questions
The self-monitoring blood glucose devices market size was valued at USD 12.82 billion in in 2022.
The key segments covered in the Self-monitoring blood glucose devices market are technology, components, application, and end-users.
The Self-monitoring blood glucose devices market key players Abbott Laboratories (U.S.), ARKRAY, Inc. (Japan), Bayer AG (Germany), Dexcom, Inc. (U.S.), Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson (U.S.), Medtronic plc (U.S.), Nipro Diagnostics, Inc. (U.S.), Terumo Medical Corporation (U.S.)
| 1.Executive Summary |
| 2.Global Self-Monitoring Blood Glucose Devices Market Introduction |
| 2.1.Global Self-Monitoring Blood Glucose Devices Market - Taxonomy |
| 2.2.Global Self-Monitoring Blood Glucose Devices Market - Definitions |
| 2.2.1.Product |
| 2.2.2.End User |
| 2.2.3.Region |
| 3.Global Self-Monitoring Blood Glucose Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Self-Monitoring Blood Glucose Devices Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Self-Monitoring Blood Glucose Devices Market By Product, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Blood Glucose Meter |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Blood Glucose Testing Strips |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Lancets |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Others |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global Self-Monitoring Blood Glucose Devices Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Clinics |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Diagnostic Centers |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Homecare |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Self-Monitoring Blood Glucose Devices Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Self-Monitoring Blood Glucose Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Blood Glucose Meter |
| 8.1.2.Blood Glucose Testing Strips |
| 8.1.3.Lancets |
| 8.1.4.Others |
| 8.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospitals |
| 8.2.2.Clinics |
| 8.2.3.Diagnostic Centers |
| 8.2.4.Homecare |
| 8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Self-Monitoring Blood Glucose Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Blood Glucose Meter |
| 9.1.2.Blood Glucose Testing Strips |
| 9.1.3.Lancets |
| 9.1.4.Others |
| 9.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals |
| 9.2.2.Clinics |
| 9.2.3.Diagnostic Centers |
| 9.2.4.Homecare |
| 9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10.Asia Pacific (APAC) Self-Monitoring Blood Glucose Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Blood Glucose Meter |
| 10.1.2.Blood Glucose Testing Strips |
| 10.1.3.Lancets |
| 10.1.4.Others |
| 10.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals |
| 10.2.2.Clinics |
| 10.2.3.Diagnostic Centers |
| 10.2.4.Homecare |
| 10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Self-Monitoring Blood Glucose Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Blood Glucose Meter |
| 11.1.2.Blood Glucose Testing Strips |
| 11.1.3.Lancets |
| 11.1.4.Others |
| 11.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals |
| 11.2.2.Clinics |
| 11.2.3.Diagnostic Centers |
| 11.2.4.Homecare |
| 11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Self-Monitoring Blood Glucose Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Blood Glucose Meter |
| 12.1.2.Blood Glucose Testing Strips |
| 12.1.3.Lancets |
| 12.1.4.Others |
| 12.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals |
| 12.2.2.Clinics |
| 12.2.3.Diagnostic Centers |
| 12.2.4.Homecare |
| 12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Abbott Laboratories (U.S.) |
| 13.2.2.ARKRAY, Inc. (Japan) |
| 13.2.3.Bayer AG (Germany) |
| 13.2.4.Dexcom, Inc. (U.S.) |
| 13.2.5.Hoffmann-La Roche Ltd (Switzerland) |
| 13.2.6.Johnson & Johnson (U.S.) |
| 13.2.7.Medtronic plc (U.S.) |
| 13.2.8.Nipro Diagnostics, Inc. (U.S.) |
| 13.2.9.Terumo Medical Corporation (U.S.) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Abbott Laboratories (U.S.)
- ARKRAY, Inc. (Japan)
- Bayer AG (Germany)
- Dexcom, Inc. (U.S.)
- Hoffmann-La Roche Ltd (Switzerland)
- Johnson & Johnson (U.S.)
- Medtronic plc (U.S.)
- Nipro Diagnostics, Inc. (U.S.)
- Terumo Medical Corporation (U.S.)